The expression level of Ki-67 has an important reference value for the diagnosis, treatment and prognosis evaluation of breast cancer. To explore the feasibility of diffusion-weighted imaging for prediction of Ki-67 expression. In this study, the expression of Ki-67 in breast cancer was differentiated by semi-automatic extraction of the image parameters of diffusion-weighted(DWI) before treatment. The results of this study show that Ki-67-negative and Ki-67-positive breast cancer have different imaging characterization values in DWI images. The imaging of DWI is feasible in identifying the two, which is helpful to predict the expression level of Ki-67 in breast cancer before operation.
[1]Denkert C, von Minckwitz G. Reply to Ki67 in breast cancer: a useful prognostic marker! [J].Ann Oncol, 2014, 25(2):542-3.
[2]Juan MW, Yu J, Peng GX, et al. Correlation between DCE-MRI radiomics features and Ki-67 expression in invasive breast cancer[J]. Oncol Lett. 2018, 16(4):5084-5090.
[3]Liang C, Cheng Z,Huang Y, et al. An MRI-based Radiomics Classifier for Preoperative Prediction of Ki-67 Status in Breast Cancer[J]. Acad Radiol. 2018,25(9):1111-1117.
[4]Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensuson the Primary Therapy of Ealy Breast Cancer 2013[J]. Ann Oncol, 2013,24(9):2206-2223.
[5]Mao N, Wang Q, Liu M, et al. Computerized Image Analysis to Differentiate Benign and Malignant Breast Tumors on Magnetic Resonance Diffusion Weighted Image: A Preliminary Study[J]. J ComputAssist Tomogr. 2019 43(1):93-97.
[6]Wang S, Li W, Liu N, et al. Clinicopathologic characteristics and prognosis for molecular subtypes in low-grade breast carcinoma: comparison with grade one invasive ductal carcinoma-not otherwise specified[J]. Med Oncol, 2012,29(4):2556-64.
[7]Brown JR, DiGiovanna MP, Killelea B, et al. Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer[J]. LabInvest, 2014, 94: 98-106.
[8]Song Y, Liu X, Zhang G, et al. Unique clinico pathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators[J]. World J Surg Oncol, 2013, 11(1):129.
[9]Boros M, Moncea D, Moldovan C, et al. Intratumoral heterogeneity for Ki-67 index in invasive breast carcinoma: a study on 131 consecutive cases[J]. ApplImmunohistochem Mol Morphol, 2017, 25:338–340.[10]Moy L, Elias K, Patel V, et al. Is breast MRI helpful in the evaluation of inconclusive mammographic findings[J].Am J Roentgenol, 2009, 193(4):986-993.
[11]Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J]. Ann Oncol, 2011,22(8):1736-1747.
[12]Chen H, Liu N, Li Y, et al. The role of dynamic contrast-enhanced MR in evaluating level III collateral circulation in a rat model of acute ischemic stroke[J].Mol Neurobiol, 2017, 54(4):2731-2738.
[13]Yuan M, Zhang YD, Zhu C, et al. Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions[J]. Magn Reson Imaging, 2016, 43(3):669-679.
[14]Choi Y, Kim SH, Youn IK, et al. Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: Comparison with ER-positive subtype[J]. PLoS One, 2017, 12(5):e0177903.
[15]Waugh SA, Purdie CA, Jordan LB, et al. Magnetic resonance imaging texture analysis classification of primary breast cancer[J]. Eur Radiol, 2016, 26(2):322-330.